Cost-Effectiveness Analysis of Thiazolidinediones in Uncontrolled Type 2 Diabetic Patients Receiving Sulfonylureas and Metformin in Thailand. Suphachai Chirakup1,2 Nathorn Chaiyakunapruk1,3,4 Usa Chaikledkeaw5,6 Petcharat Pongcharoensuk5 Boonsong Ongphiphadhanakul7 Stephane Roze8 William J. Val

Strengthening Cost-Effectiveness Analysis in Thailand through the Establishment of the Health Intervention and Technology Assessment Program. Tantivess S1 Teerawattananon Y1 Mills A1 1 Health Intervention and Technology Assessment Program, Ministry of Public Health, Nonthaburi, Thailand 2 London

In this issue, the main article will focused on how HTA units in the Asian-Pacific region communicate with their stakeholders in order to push forward their research result. Secondly, we recently greet our two new members, HealthPact (Australia) and Department of Health (the Philippines), therefo

Provider-initiated HIV/AIDS counselling and testing at healthcare facilities in Thailand: a cluster-randomisation trial. Yot Teerawattananon1, Yuwadee Leelukkanaveera1,2,3, Montarat Thavorncharoensap1,4, Piya Hanvoravongchai5, Lily Ingsrisawang1,6, Sripen Tantivess1, Usa Chaikledkaew1,4, Adun Mohar

A cost-utility and budget impact analysis of allogeneic hematopoietic stem cell transplantation for severe thalassemic patients in Thailand. Pattara Leelahavarong1,2, Usa Chaikledkaew1,2*, Suradej Hongeng3, Vijj Kasemsup4, Yoel Lubell1,5, Yot Teerawattananon1 1Health Intervention and Technolog

Scaling up health policies and services in low- and middle-income settings. Kara Hanson1*, Susan Cleary2, Helen Schneider3, Sripen Tantivess4, Lucy Gilson1,5 1Department of Global Health and Development, London School of Hygiene and Tropical Medicine, UK. 2Health Economics Unit, University of Cap

COVID-19 has been inevitably staying with us for almost a year and a half since the first outbreak. It induces us to seek for more knowledge in order to survive and control this harsh situation, not only from healthcare perspective but also economic and political ones. HTA is a great helping hand fo

Economic Evaluation of Policy Options for Prevention and Control of Cervical Cancer in Thailand Naiyana Praditsitthikorn,1,2 Yot Teerawattananon,1,3 Sripen Tantivess,1,3 Supon Limwattananon,3 Arthorn Riewpaiboon,2 Saibua Chichareon,4 Nantakan Ieumwananonthachai5 and Viroj Tangcharoensathien3

Economic Evaluation of Rehabilitation Services for Inpatients with Stroke in Thailand: A Prospective Cohort Study. Orathai Khiaocharoen, BN, PhD1, , , , Supasit Pannarunothai, MD, PhD2, Wachara Riewpaiboon,MD3, Lily Ingsrisawang, BSc, PhD4, Yot Teerawattananon, MD, PhD5 1 Hea

Advanced health biotechnologies in Thailand: redefining policy directions. Román Pérez Velasco1*, Usa Chaikledkaew2,3, Chaw Yin Myint2 , Roongnapa Khampang2 , Sripen Tantivess2 and Yot Teerawattananon2* Abstract Background: Thailand faces a significant burden in terms of treating and managi